FBXO8: A Potential Drug Target and Biomarker (G26269)

Target Name: FBXO8

NCBI ID: G26269

FBXO8

FBXO8: A Potential Drug Target and Biomarker

Fingerprint ID: FBXO8

Target Name: FBXO8

Description: FBXO8 is a protein that is expressed in various tissues and cells, including the brain, heart, and kidneys. It is a member of the superfamily of ubiquitin nucleases and is involved in the detoxification of xenobiotics and other harmful substances. FBXO8 has also been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation.

FBXO8 is a potential drug target due to its involvement in multiple cellular processes that are associated with a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also a potential biomarker for these diseases, as its levels may be affected by the use of certain drugs.

The mechanism of action of FBXO8 is still being explored, but it is known to play a negative role in the detoxification of certain xenobiotics, such as arsenic and cadmium. It is also involved in the regulation of cellular processes that are important for the survival and proliferation of cells, such as cell apoptosis.

FBXO8 has been shown to play a role in the regulation of cellular apoptosis, which is the process by which cells undergo programmed cell death. This process is important for the development and progression of many diseases, including cancer.

In addition to its role in apoptosis, FBXO8 has also been shown to play a role in the regulation of cell proliferation. It is known to inhibit the activity of cell cycle proteins, which are important for the growth and proliferation of cells. This may be important for the development of cancer.

FBXO8 has also been shown to play a role in the regulation of inflammation. It is involved in the detoxification of certain inflammatory compounds, such as arachidonic acid, which is a potent cause of inflammation. This may be important for the development of inflammatory diseases, such as rheumatoid arthritis.

The potential drug targets for FBXO8 are being explored for its ability to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. FBXO8 has been shown to be effective in animal models of these diseases, and clinical trials are being conducted to evaluate its potential as a drug.

In conclusion, FBXO8 is a protein that is involved in multiple cellular processes that are important for the development and progression of many diseases. Its potential drug targets and biomarker status make it an attractive target for research into the treatment of these diseases. Further studies are needed to fully understand its mechanism of action and to determine its potential as a drug.

Protein Name: F-box Protein 8

Functions: May promote guanine-nucleotide exchange on an ARF. Promotes the activation of ARF through replacement of GDP with GTP (Potential)

The "FBXO8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FBXO8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets